NeurOptics Inc
5
1
1
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy
Role: lead
Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care
Role: collaborator
Inter-Device Reliability of the NPi-300 Pupillometer
Role: collaborator
Utility of Pupillary Metrics in Diagnosis and Management of Concussion in Children
Role: collaborator
Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy
Role: collaborator
All 5 trials loaded